Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations

Aim: to evaluate the efficacy of cyclopheron used in patients with mild clinical manifestations of focal and infiltrative pulmonary tuberculosis (PT). Subjects and methods. Thirty first detected patients with PT, in whom a complex of their etiotropic therapy comprised cyclopheron, and 32 similar pat...

Full description

Bibliographic Details
Main Authors: Tat'yana Pavlovna Filippova, Lyudmila Sergeevna Vasil'eva, Aleksandr Viktorovich Kochkin, T P Filippova, L S Vasilyeva, A V Kochkin
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2010-11-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30742
_version_ 1818326813191962624
author Tat'yana Pavlovna Filippova
Lyudmila Sergeevna Vasil'eva
Aleksandr Viktorovich Kochkin
T P Filippova
L S Vasilyeva
A V Kochkin
author_facet Tat'yana Pavlovna Filippova
Lyudmila Sergeevna Vasil'eva
Aleksandr Viktorovich Kochkin
T P Filippova
L S Vasilyeva
A V Kochkin
author_sort Tat'yana Pavlovna Filippova
collection DOAJ
description Aim: to evaluate the efficacy of cyclopheron used in patients with mild clinical manifestations of focal and infiltrative pulmonary tuberculosis (PT). Subjects and methods. Thirty first detected patients with PT, in whom a complex of their etiotropic therapy comprised cyclopheron, and 32 similar patients who received etiotropic agents and placebo were examined. Tuberculosis process activity was confirmed by clinical, X-ray, bacteriological, and immunological studies. The hypothalamic-pituitary-adrenal system was determined from serum cortisol concentration. The sympathoadrenal system was assessed from cardiac rhythm parameters (autonomic balance index). Results. Incorporation of cyclopheron into the combined therapy of patients with PT led to increased blood cortisol concentration, higher autonomic balance index, elevated T-lymphocyte count, enhanced phagocytic activity, and lower levels of circulating immune complexes, resulting in earlier decay cavity closure and sputum negativation. Conclusion. Extrastress status of adaptation systems and the absence of their activating impact on immunity and inflammation are detectable in first detected patients with mild clinical manifestations of PT running in significant lung tissue fibrosis. Therapy with cyclopheron that stimulates the production of stress-induced cytokines gives rise to a stress reaction, activates immune processes, and enhances therapeutic effectiveness in this group of patients.
first_indexed 2024-12-13T12:06:20Z
format Article
id doaj.art-9b8fe5666d914007b7d2764511341e00
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-13T12:06:20Z
publishDate 2010-11-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-9b8fe5666d914007b7d2764511341e002022-12-21T23:46:57Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422010-11-018211495327769Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestationsTat'yana Pavlovna FilippovaLyudmila Sergeevna Vasil'evaAleksandr Viktorovich KochkinT P Filippova0L S Vasilyeva1A V Kochkin2Irkutsk State Medical UniversityIrkutsk State Medical UniversityIrkutsk State Medical UniversityAim: to evaluate the efficacy of cyclopheron used in patients with mild clinical manifestations of focal and infiltrative pulmonary tuberculosis (PT). Subjects and methods. Thirty first detected patients with PT, in whom a complex of their etiotropic therapy comprised cyclopheron, and 32 similar patients who received etiotropic agents and placebo were examined. Tuberculosis process activity was confirmed by clinical, X-ray, bacteriological, and immunological studies. The hypothalamic-pituitary-adrenal system was determined from serum cortisol concentration. The sympathoadrenal system was assessed from cardiac rhythm parameters (autonomic balance index). Results. Incorporation of cyclopheron into the combined therapy of patients with PT led to increased blood cortisol concentration, higher autonomic balance index, elevated T-lymphocyte count, enhanced phagocytic activity, and lower levels of circulating immune complexes, resulting in earlier decay cavity closure and sputum negativation. Conclusion. Extrastress status of adaptation systems and the absence of their activating impact on immunity and inflammation are detectable in first detected patients with mild clinical manifestations of PT running in significant lung tissue fibrosis. Therapy with cyclopheron that stimulates the production of stress-induced cytokines gives rise to a stress reaction, activates immune processes, and enhances therapeutic effectiveness in this group of patients.https://ter-arkhiv.ru/0040-3660/article/view/30742tuberculosisstressadaptationcyclopheron
spellingShingle Tat'yana Pavlovna Filippova
Lyudmila Sergeevna Vasil'eva
Aleksandr Viktorovich Kochkin
T P Filippova
L S Vasilyeva
A V Kochkin
Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
Терапевтический архив
tuberculosis
stress
adaptation
cyclopheron
title Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
title_full Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
title_fullStr Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
title_full_unstemmed Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
title_short Use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
title_sort use of cyclopheron in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations
topic tuberculosis
stress
adaptation
cyclopheron
url https://ter-arkhiv.ru/0040-3660/article/view/30742
work_keys_str_mv AT tatyanapavlovnafilippova useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations
AT lyudmilasergeevnavasileva useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations
AT aleksandrviktorovichkochkin useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations
AT tpfilippova useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations
AT lsvasilyeva useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations
AT avkochkin useofcyclopheroninthetreatmentofpatientswithpulmonarytuberculosiswithmildclinicalmanifestations